Brady James Aloysius

CIK 00019169872 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001916987

Recent Transactions

18 trades

Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2026-06-04$6.15/sh+32,996→ 32,996 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2026-06-04+24,193→ 113,359 total
Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2026-03-30$5.54/sh−10,834→ 89,166 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−288,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−23,176→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Share Unit
2025-10-07−72,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−96,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2025-10-07−240,000→ 0 total
Disposition to Issuer
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07−72,000→ 0 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-10-07+72,000→ 72,000 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01$13.14/sh−824→ 23,176 total
Exercise/Conversion
Verona Pharma plc$VRNA
Restricted Stock Units
2025-08-01−24,000→ 72,000 total
Exercise/Conversion
Verona Pharma plc$VRNA
Ordinary Shares
2025-08-01+24,000→ 24,000 total
Award
Verona Pharma plc$VRNA
Restricted Share Units
2025-04-25+96,000→ 96,000 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-03-28+100,000→ 100,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2024-04-29+240,000→ 240,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2023-04-28+96,000→ 96,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2022-03-14+288,000→ 288,000 total

Companies

Recent Filings

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607

View on SEC.gov